IVD Medical Holding Limited

HKEX:1931.HK

1.63 (HKD) • At close November 14, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22017 Q12016 Q42016 Q22016 Q12015 Q4
Revenue 1,353.471,711.0731,377.3141,572.2521,176.5571,543.8791,186.7911,446.97981.241,419.977912.763242.747170.888103.40984.56784.56784.56772.6172.6172.61
Cost of Revenue 1,028.7781,340.9121,075.7741,230.534910.1341,217.5946.9021,164.984787.0611,131.007698.535170.619126.34574.24157.51457.51457.51451.63651.63651.636
Gross Profit 324.692370.161301.54341.718266.423326.379239.889281.986194.179288.97214.22872.12844.54329.16827.05427.05427.05420.97520.97520.975
Gross Profit Ratio 0.240.2160.2190.2170.2260.2110.2020.1950.1980.2040.2350.2970.2610.2820.320.320.320.2890.2890.289
Reseach & Development Expenses 3.7664.6084.0574.3642.8554.2493.0251.9181.5981.5411.1990.4320.2840.550.1490.1490.1490.0290.0290.029
General & Administrative Expenses 76.16988.04771.93375.80277.408104.65879.19258.28785.80383.15741.51931.5523.1465.8172.3012.3012.3013.293.293.29
Selling & Marketing Expenses 60.0975.74560.56871.2445.99976.29146.27765.76439.91662.61234.0086.425.2112.9082.5762.5762.5762.9212.9212.921
SG&A 136.825162.926132.409149.133124.01180.482126.736120.264128.837146.53675.05138.92129.7418.7254.8774.8774.8776.2116.2116.211
Other Expenses 000000000000010.3369.2489.2489.2486.8396.8396.839
Operating Expenses 140.591167.534129.641143.833151.911166.951112.71399.738122.827329.61126.884.0994.67319.6114.27414.27414.27413.07913.07913.079
Operating Income 184.101202.627169.131192.585142.413145.897113.153161.72265.342142.434139.17733.2114.79930.38931.61531.61531.61516.31516.31516.315
Operating Income Ratio 0.1360.1180.1230.1220.1210.0950.0950.1120.0670.10.1520.1370.0870.2940.3740.3740.3740.2250.2250.225
Total Other Income Expenses Net -3.61-26.207-2.165-7.927-36.0637.3348.8311.799-4.989-183.477201.54643.40726.206-0.9830.4650.4650.4650.20.20.2
Income Before Tax 180.491176.42162.909180.294103.495148.982118.958171.60360.353-42.584339.52476.61741.00529.40632.0832.0832.0816.51516.51516.515
Income Before Tax Ratio 0.1330.1030.1180.1150.0880.0960.10.1190.062-0.030.3720.3160.240.2840.3790.3790.3790.2270.2270.227
Income Tax Expense 52.92543.29658.90754.46533.79464.59341.59753.07724.2611.73743.85812.2725.8424.5293.9313.9313.9312.2242.2242.224
Net Income 125.288135.154103.009128.8581.14995.65478.887120.43738.281-23.502298.50367.32536.11524.87728.14928.14928.14914.29214.29214.292
Net Income Ratio 0.0930.0790.0750.0820.0690.0620.0660.0830.039-0.0170.3270.2770.2110.2410.3330.3330.3330.1970.1970.197
EPS 0.0930.10.0760.0950.060.0710.0590.090.029-0.040.310.110.0580.0190.0210.0210.0210.0110.0110.011
EPS Diluted 0.0930.10.0760.0950.060.0710.0590.090.029-0.0180.310.110.0590.0190.0210.0210.0210.0110.0110.011
EBITDA 199.876219.522180.812202.171155.371160.616125.556172.9177.135169.646149.15443.26622.48934.82535.27935.27935.27919.01619.01619.016
EBITDA Ratio 0.1480.1280.1310.1290.1320.1040.1060.1190.0790.1190.1630.1780.1320.3370.4170.4170.4170.2620.2620.262